Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Peritoneal Neoplasms 1Ovarian Cysts 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × FloSeal Matrix × Gynecologic × Clear all
NCT01957852 2015-02-25

FloSeal in CRS and HIPEC

Maisonneuve-Rosemont Hospital

Completed
86 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01857466 2014-06-25

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CHA University

Phase 3 Completed
100 enrolled
Gynecologic

Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡